Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global multiplexed diagnostics market size was valued at USD 12.9 billion in 2023, with North America holding a substantial market share. The market is driven by the advancements in multiplexing technologies. It is expected to grow at a CAGR of 15.2% during the forecast period of 2024-2032, with the values likely to attain USD 46.2 billion by 2032.
Multiplexing is characterized by the simultaneous detection or identification of multiple biomarkers in a single diagnostic test. Multiplexed detection of biomarkers in certain diseases helps in accurately diagnosing the patient, as well as selecting the appropriate therapy. Thus, multiplexed diagnostic methods improve patient outcomes along with decreasing associated healthcare costs. Further, advancements in these techniques have led to increased efficiency and output, resulting in higher adoption in clinical laboratories and boosting North America multiplexed diagnostics market growth.
The rise in chronic disease burden including cardiovascular diseases and cancer positively impacts the market size. Recent data suggests that nearly half of Americans have some type of heart disease . Moreover, 1 in 5 deaths in the United States are caused by a heart disease annually. Multiplexed diagnostics can prove to be valuable in getting actionable health insights for cardiovascular disease patients in lesser time and cost. The multiplex detection of relevant biomarkers can not only reveal the pathophysiology of the disease but also help in picking the most effective treatment plan, thereby, propelling the North America multiplexed diagnostics market demand.
In April 2023, Sapphiros AI Bio, a United States-based computational biology company announced its selection in the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) program, receiving USD 11.1 million as part of the NIH initiative to develop an over the counter (OTC) multiplex molecular respiratory diagnostic test. The firm intends to use the funds to design an easy-to-use, affordable, and rapidly deployable diagnostic method for the detection of influenza A, influenza B, respiratory syncytial virus (RSV), and COVID-19 in a single test. The increased investment from various sectors to advance diagnostic technologies, particularly government initiatives that offer robust financial aid, are expected to augment North America multiplexed diagnostics market share.
In February 2024, PathogenDx, a next-generation microarray technology provider based in Arizona, United States, launched D3 Array™-UTI, a multiplexed molecular diagnostic technology based on PathogenDx’s patented Dynamic Dimensional Detection (D3 Array™) to detect urinary tract infection and antibiotic resistance. The multiplexed PCR test, with automated data analysis and reporting, can detect 26 pathogens and 12 antibiotic resistance gene markers, thereby advancing UTI diagnosis, and improving patient outcomes. The introduction of such technologically advanced multiplexed diagnostic platforms that can assist clinicians in delivering rapid treatment to patients is poised to significantly elevate the market value in the forecast period.
The report offers a detailed analysis of the market based on the following segments:
Market Breakup | Categories |
Product Type | Reagents & Consumables, Instruments, Others |
Technology | Low Density Multiplexed Assays, Medium Density Multiplexed Assays, High Density Multiplexed Assays, Very High-Density Multiplexed assays, Next-Generation Sequencing Assays, Others |
Application | Disease Diagnostics, Drug Development, Molecular Diagnostics, Others |
End User | Hospitals, Clinical Laboratories, Academic & Research Institutes, Diagnostics Centers, Others |
Countries | United States of America, Canada |
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Technology |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The North America multiplexed diagnostics market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 15.2% during the forecast period of 2024-2032 and is likely to reach a market value of USD 46.2 billion by 2032.
Technological advancements in the multiplexed diagnostics platforms are fuelling the demand for the market.
One of the significant trends in the market is increased funding from government organizations to advance diagnostic technologies. In April 2023, Sapphiros AI Bio received USD 11.1 million from a National Institutes of Health (NIH) initiative, intended to develop an over the counter (OTC) multiplex molecular respiratory diagnostic test.
Based on the product type, the market is segmented into reagents, consumables, and instruments, among others.
Technologies available in the market include low density multiplexed assays, medium density multiplexed assays, high density multiplexed assays, very high-density multiplexed assays, and next-generation sequencing assays, among others.
End users of the market are hospitals, clinical laboratories, academic and research institutes, and diagnostics centers, among others.
Major applications of multiplexed diagnostics include disease diagnostics, drug development, and molecular diagnostics, among others.
The market segmentation by countries includes the United States of America and Canada.
The key players in the market are Thermo Fisher Scientific Inc., Agilent Technologies, BioMerieux SA, Bio-Rad Laboratories, Illumina, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Qiagen N.V., Siemens Healthineers, and Luminex Corporation.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share